Medical Congress News

Medical Digest & Congress Report

Health EN ↓ 808 episoder

The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.

Husk å besøke podkastens nettsted og støtte skaperen: medicaldigest.org

Forfatter

Medical Congress News

Kategori

Health

Podkastens nettsted

medicaldigest.org

Siste episode

20. nov 2026

Hvor kan du lytte?

Podkaster i appen Replaio Radio Kommer snart

Podkaster kommer snart til appen. Installer nå, og bli den første som ser en helt ny tilnærming til podkaster

Last ned på Google Play Installer gratis Android 10 mill.+ nedlastinger · 4,7+ i vurdering iOS snart

Episoder

Renal Outcomes and Cardiorenal Mechanisms in Type 2 Diabetes: Highlights from the FLOW and ACHIEVE-4 Trials - report from EASD 2026 13.10.2026

Dr. Katherine Tuttle presents key insights on cardiorenal protection in type 2 diabetes at the EASD 2026 Congress, drawing from both the FLOW and ACHIEVE-4 trials. This brief highlights novel proteomic biomarker analyses explaining the pathways of kidney protection in FLOW, alongside clinical data from the ACHIEVE-4 trial comparing the renal outcomes of oral orforglipron versus insulin glargine in...

Effect of CagriSema on Composite HbA1c and Body Weight Reduction Targets in Type 2 Diabetes: REIMAGINE 1 - report from EASD 2026 13.10.2026

Dr. Akshay Jain presents key findings from the REIMAGINE 1 trial on CagriSema at the EASD 2026 Congress. This brief highlights clinical evidence on the efficacy of CagriSema in achieving composite HbA1c and significant body weight reduction targets, demonstrating the potential of dual-action therapy in managing type 2 diabetes and metabolic risk. Video: https://medicaldigest.org/scientific-content...

Early Intervention, Lasting Benefit: Reshaping the Obesity Treatment Paradigm - report from EASD 2026 13.10.2026

Dr. Arya Sharma presents key insights into reshaping the obesity treatment paradigm through early intervention at the EASD 2026 Congress. This brief highlights the long-term clinical benefits of proactive weight management, addressing the underlying drivers of metabolic disease early, and transitioning toward sustained, lifelong therapeutic approaches for obesity. Video: https://medicaldigest.org/...

Early Approvals, Real-World Insights, and Emerging Therapies in MASLD Care - report from EASD 2026 13.10.2026

Dr. Michael Roden presents key insights from the EASD-EASL joint session on metabolic dysfunction-associated steatotic liver disease (MASLD) at the EASD 2026 Congress. This brief highlights early therapeutic approvals, real-world clinical data, and novel emerging treatments aimed at optimizing multidisciplinary care and improving outcomes for patients with MASLD and metabolic risk factors. Video:...

The Implementation Imperative: Closing the Gap in Diabetes Care - report from EASD 2026 13.10.2026

Dr. Amisha Wallia presents key insights from the EASD-ADA joint session on closing the implementation gap in diabetes care at the EASD 2026 Congress. This brief highlights evidence-based implementation strategies, discussing pathways to overcome system-level barriers, translate clinical guidelines into routine practice, and achieve equitable care delivery for patients with diabetes. Video: https:/...

ACASA-TAVI: Antithrombotic Therapy After TAVI - report from ESC 2026 10.09.2026

Prof. Oyvind H. Lie presents trial findings on antithrombotic management following transcatheter aortic valve implantation (TAVI) at the ESC Congress 2026, evaluating optimal regimen strategies to balance ischemic risk reduction and bleeding complications. Video: https://medicaldigest.org/scientific-contents/interview:acasa-tavi-antithrombotic-therapy-after-tavi

REACT: Prevalence of Silent Atherosclerosis Across Adult Life - report from ESC 2026 10.09.2026

Prof. Henning Bundgaard presents landmark data from the REACT study at the ESC Congress 2026, mapping the prevalence of silent atherosclerosis across early to late adulthood and highlighting the role of early vascular imaging in primary prevention. Video: https://medicaldigest.org/scientific-contents/interview:react-prevalence-silent-atherosclerosis-across-adult-life

LDL Cholesterol Management in CAD: From ARMYDA to AMUNDSEN - report from ESC 2026 10.09.2026

Prof. Giuseppe Patti tracks the evolution of low-density lipoprotein cholesterol management in coronary artery disease at the ESC Congress 2026, drawing insights from the ARMYDA trials to the landmark AMUNDSEN study to optimize lipid-lowering strategies. Video: https://medicaldigest.org/scientific-contents/interview:ldl-cholesterol-management-cad-armyda-amundsen

Comorbidities Require Special Attention in Atrial Fibrillation - report from ESC 2026 10.09.2026

Prof. Ratika Parkash explores the critical role of managing comorbid conditions in atrial fibrillation at the ESC Congress 2026, emphasizing tailored risk factor modification and comprehensive multidisciplinary care. Video: https://medicaldigest.org/scientific-contents/interview:comorbidities-require-special-attention-atrial-fibrillation

How to Personalise the Treatment of Atrial Fibrillation - report from ESC 2026 10.09.2026

Prof. Helmut Puererfellner explores tailored approaches to atrial fibrillation management at the ESC Congress 2026, focusing on patient-specific symptom burdens, ablation vs. medical therapy, and targeted risk factor modification. Video: https://medicaldigest.org/scientific-contents/interview:how-personalise-treatment-atrial-fibrillation

2026 ESC Guidelines for the Management of Cardiovascular Disease and Chronic Kidney Disease 10.09.2026

Prof. Kevin Damman outlines the new 2026 ESC Guidelines for managing cardiorenal syndrome at the ESC Congress 2026, focusing on early intervention, risk stratification, and integrated treatment approaches for co-existing CVD and CKD. Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-management-cardiovascular-disease-and-chronic-kidney-disease

Practical Implementation of the ESC Atrial Fibrillation Guideline - report from ESC 2026 10.09.2026

Prof. Michiel Rienstra discusses the practical implementation of the ESC Atrial Fibrillation Guidelines at the ESC Congress 2026, offering actionable strategies to streamline clinical workflows and optimize patient care. Video: https://medicaldigest.org/scientific-contents/interview:practical-implementation-esc-atrial-fibrillation-guideline

2026 ESC Guidelines for the Management of Heart Failure - report from ESC 2026 10.09.2026

Prof. Marianna Adamo outlines the updated 2026 ESC Guidelines for the Management of Heart Failure at the ESC Congress 2026, highlighting essential advances in diagnosis, early therapy initiation, and disease management. Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-management-heart-failure

SWITCH SWEDEHEART: Switching Ticagrelor to Prasugrel in ACS - report from ESC 2026 10.09.2026

Prof. Elmir Omerovic presents key results from the SWITCH SWEDEHEART trial at the ESC Congress 2026, evaluating the safety and efficacy of switching from ticagrelor to prasugrel in patients with acute coronary syndromes. Video: https://medicaldigest.org/scientific-contents/interview:switch-swedeheart-switching-ticagrelor-prasugrel-acs

From Guidelines to Clinical Impact: Key Takeaways on GDMT Implementation – Report from ESC 2026 10.09.2026

Prof. Piotr Ponikowski discusses the critical gap between heart failure guidelines and real-world clinical practice, exploring the missing pieces needed for successful guideline-directed medical therapy (GDMT) implementation. Video: https://medicaldigest.org/scientific-contents/interview:guidelines-clinical-impact-key-takeaways-gdmt-implementation-report-esc-2026

Start Early, Start in Hospital: Translating Heart Failure Guidelines into Practice - report from ESC 2026 10.09.2026

Prof. Shelley Zieroth addresses the critical importance of early, in-hospital initiation of guideline-directed medical therapy for heart failure at the ESC Congress 2026, highlighting practical strategies to improve patient outcomes during post-discharge transition. Video: https://medicaldigest.org/scientific-contents/interview:start-early-start-hospital-translating-heart-failure-guidelines-practi...

Main Highlights and Key Clinical Takeaways of ESC 2026 10.09.2026

Prof. Felix Mahfoud summarizes the main highlights and key clinical takeaways from the ESC Congress 2026, showcasing practice-changing trial results, new guidelines, and breakthroughs across AI, cardiometabolic disease, and interventional cardiology. Video: https://medicaldigest.org/scientific-contents/interview:main-highlights-and-key-clinical-takeaways-esc-2026

From Guidelines to Clinical Impact: GDMT Implementation - report from ESC 2026 10.09.2026

Prof. Giuseppe Rosano addresses key challenges in implementing guideline-directed medical therapy at the ESC Congress 2026, exploring strategies to bridge the gap between clinical recommendations and real-world cardiovascular care. Video: https://medicaldigest.org/scientific-contents/interview:guidelines-clinical-impact-gdmt-implementation

SINGLE-AF: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk - report from ESC 2026 10.09.2026

Prof. Boyoung Joung presents findings from the landmark SINGLE-AF trial at the ESC Congress 2026. The study demonstrates that direct oral anticoagulants (DOACs) significantly reduce stroke risk in atrial fibrillation patients at intermediate risk without increasing major bleeding. Video: https://medicaldigest.org/scientific-contents/interview:single-af-anticoagulation-atrial-fibrillation-intermedi...

ENRICH-AF: Edoxaban in Intracranial Hemorrhage Survivors with Atrial Fibrillation - report from ESC 2026 10.09.2026

Prof. Ashkan Shoamanesh presents key findings from the ENRICH-AF trial at the ESC Congress 2026. The study evaluates whether edoxaban safely reduces stroke risk in high-risk atrial fibrillation patients with a history of intracranial hemorrhage, highlighting crucial trade-offs between ischemic stroke prevention and major bleeding risks. Video: https://medicaldigest.org/scientific-contents/intervie...

5th Universal Definition of Myocardial Infarction - report from ESC 2026 10.09.2026

Prof. Kristin Newby breaks down the new 5th Universal Definition of Myocardial Infarction at the ESC Congress 2026, highlighting refined diagnostic criteria and global clinical consensus. Video: https://medicaldigest.org/scientific-contents/interview:5th-universal-definition-myocardial-infarction

2026 ESC Guidelines on Cardiac Rehabilitation 10.09.2026

Prof. Matthias Wilhelm outlines the updated 2026 ESC Guidelines on Cardiac Rehabilitation at the ESC Congress 2026, focusing on personalized training and modern secondary prevention strategies. Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-cardiac-rehabilitation

Control the modifiable risk factors to prevent dementia: Insights from the 10/66 studies 28.07.2026

Professor Daisy Acosta delivers an essential expert overview on the shifting landscape of dementia prevalence across Latin America, building on crucial insights from the 10/66 studies. This concise brief highlights the unexpected increase in dementia prevalence over the past two decades across multiple catchment sites, contrasting sharply with the declining trends observed in high-income countries...

The New Landscape of Alzheimer’s Therapy: Targets, Treatments, and Future Outlook 22.07.2026

Professor Takaomi C. Saido, world renowned scientist, delivers a comprehensive expert overview on the current state of Alzheimer's disease research, moving past traditional models to explore groundbreaking therapeutic targets. This concise brief highlights the mechanisms behind approved disease-modifying therapies, the crucial role of neprilysin and somatostatin receptor in amyloid clearance,...

Highlights of ISTH Guidelines and Guidance Documents - report from ISTH 2026 21.07.2026

Dr. James Douketis delivers an essential overview of the key highlights from the newly updated ISTH guidelines and guidance documents at the ISTH 2026 Congress. This targeted brief focuses on practical, evidence-based clinical recommendations, highlighting two major clinical updates: Surgical and Procedural Bleed Risk Stratification for Anticoagulated Patients Undergoing Planned Surgery – A refine...

Hør på podkasten Medical Digest & Congress Report i Replaio

Radio og podkaster i én app - gratis og uten registrering. Installer i dag, og ikke gå glipp av lanseringen

Last ned på Google Play

Replaio er ikke podkastutgiver; programnavn, omslag og lyd tilhører opphavspersonene og distribueres via offentlige RSS-feeder.